A. Ishida et al., CIRCULATING ENDOGENOUS THROMBOPOIETIN, INTERLEUKIN-3, INTERLEUKIN-6 AND INTERLEUKIN-11 LEVELS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROWTRANSPLANTATION, International journal of hematology, 65(1), 1996, pp. 61-69
To elucidate the physiologic role of thrombopoietin (TPO) for hematolo
gic reconstitution following alogeneic bone marrow transplantation (BM
T), serum TPO levels as well as interleukin-3 (IL-3), IL-6 and IL-11 w
ere serially measured in 55 samples from 3 patients who underwent allo
geneic BMT using an enzyme-linked immunosorbent assay (ELISA). The TPO
level was higher in the serum taken during marrow aplasia than in the
pretransplant serum. The serum TPO levels and platelet counts showed
a strong inverse relationship in all patients examined. We also sequen
tially measured endogenous serum TPO levels before and within 36 h aft
er platelet transfusions. Endogenous serum TPO levels were inversely c
orrelated with platelet mass following platelet transfusions. Serum le
vels of IL-3 had no apparent correlation with platelet counts and seru
m levels of IL-11 remained below the detection levels (31.3 pg/ml) in
all samples. Serum levers of IL-6 were high during myeloaplasia and mo
re upregulated in the febrile period. These findings support the view
that TPO is the central regulator for megakaryopoiesis in vivo and the
rationale for its clinical use after allogeneic BMT.